5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells

被引:0
|
作者
Enxian Shi
Zhengquan Wu
Birnur Sinem Karaoglan
Sabina Schwenk-Zieger
Gisela Kranz
Nilofer Abdul Razak
Christoph A. Reichel
Martin Canis
Philipp Baumeister
Reinhard Zeidler
Olivier Gires
机构
[1] LMU University Hospital,Department of Otorhinolaryngology, Head and Neck Surgery
[2] LMU Munich,undefined
[3] Institute of Structural Biology,undefined
[4] Research Unit Therapeutic Antibodies,undefined
关键词
CD73; EGFR; EMT; Invasion; Antagonistic antibody; HNSCC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 47 条
  • [1] 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells
    Shi, Enxian
    Wu, Zhengquan
    Karaoglan, Birnur Sinem
    Schwenk-Zieger, Sabina
    Kranz, Gisela
    Razak, Nilofer Abdul
    Reichel, Christoph A.
    Canis, Martin
    Baumeister, Philipp
    Zeidler, Reinhard
    Gires, Olivier
    JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
  • [2] Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5′-nucleotidase (CD73)
    Snider, Natasha T.
    Altshuler, Peter J.
    Wan, Shanshan
    Welling, Theodore H.
    Cavalcoli, James
    Omary, M. Bishr
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (25) : 4024 - 4033
  • [3] MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
    Bonnin, Nathalie
    Armandy, Emma
    Carras, Julien
    Ferrandon, Sylvain
    Battiston-Montagne, Priscillia
    Aubry, Marc
    Guihard, Sebastien
    Meyronet, David
    Foy, Jean-Philippe
    Saintigny, Pierre
    Ledrappier, Sonia
    Jung, Alain
    Rimokh, Ruth
    Rodriguez-Lafrasse, Claire
    Poncet, Delphine
    ONCOTARGET, 2016, 7 (28) : 44023 - 44038
  • [4] Controlling the Immune Suppressor: Transcription Factors and MicroRnAs Regulating CD73/NT5E
    Kordass, Theresa
    Osen, Wolfram
    Eichmueller, Stefan B.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] RETRACTION: CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway
    Zhang, H.
    Cao, Y.
    Tang, J.
    Wang, R.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [6] NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
    Wang, H.
    Lee, S.
    Lo Nigro, C.
    Lattanzio, L.
    Merlano, M.
    Monteverde, M.
    Matin, R.
    Purdie, K.
    Mladkova, N.
    Bergamaschi, D.
    Harwood, C.
    Syed, N.
    Szlosarek, P.
    Briasoulis, E.
    McHugh, A.
    Thompson, A.
    Evans, A.
    Leigh, I.
    Fleming, C.
    Inman, G. J.
    Hatzimichael, E.
    Proby, C.
    Crook, T.
    BRITISH JOURNAL OF CANCER, 2012, 106 (08) : 1446 - 1452
  • [7] Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance
    Jain, Drishti
    Somasundaram, Dinesh Babu
    Aravindan, Sheeja
    Yu, Zhongxin
    Baker, Ashley
    Esmaeili, Azadeh
    Aravindan, Natarajan
    CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (03) : 967 - 989
  • [8] Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance
    Drishti Jain
    Dinesh Babu Somasundaram
    Sheeja Aravindan
    Zhongxin Yu
    Ashley Baker
    Azadeh Esmaeili
    Natarajan Aravindan
    Cell Biology and Toxicology, 2023, 39 : 967 - 989
  • [9] CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers
    Li, Huisheng
    Xie, Peng
    Li, Ping
    Du, Yuheng
    Zhu, Jiajia
    Yuan, Yudong
    Wu, Chao
    Shi, Yantao
    Huang, Zhiyong
    Wang, Xudong
    Liu, Dongying
    Liu, Weishuai
    ADVANCED BIOLOGY, 2023, 7 (02):
  • [10] NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
    H Wang
    S Lee
    C Lo Nigro
    L Lattanzio
    M Merlano
    M Monteverde
    R Matin
    K Purdie
    N Mladkova
    D Bergamaschi
    C Harwood
    N Syed
    P Szlosarek
    E Briasoulis
    A McHugh
    A Thompson
    A Evans
    I Leigh
    C Fleming
    G J Inman
    E Hatzimichael
    C Proby
    T Crook
    British Journal of Cancer, 2012, 106 : 1446 - 1452